Breaking News on Global Pharmaceutical Technology & Manufacturing

Ingredients: Top Headlines

News in brief

US bans drugs and all but one API made at three IPCA Labs plants

21-Jun-2017 - The US FDA has banned all drugs and all but one of the APIs made by Ipca Laboratories at its facilities in Ratlam, Indore and Piparia.

Anhui Sunhere awarded patent for enzyme-based starch solubilization method

20-Jun-2017 - Anhui Sunhere Pharmaceutical Excipients has been granted a Chinese patent for an enzyme-based method of making starch soluble.

A change of focus: B-MS sells Irish API plant to Korean SK Biotek

19-Jun-2017 - Bristol-Myers Squibb (B-MS) has announced it will sell its Swords, Ireland-based API manufacturing facility as part of its focus on biologics.

Update with comment from MHRA

Europe tells API firms UK will be a “third country” like India and China after Brexit

15-Jun-2017 - The European Commission has confirmed that UK API manufacturers will have to supply European customers with written confirmation their products are made in compliance with EU standards after Brexit.


AstraZeneca made Eliquis recalled in US says Bristol Myers-Squibb

15-Jun-2017 - Bristol Myers Squibb (B-MS) says the lot of Eliquis recalled in the US this week was made by AstraZeneca’s contract manufacturing business.

Dr Reddy's says US FDA has closed Miryalaguda plant audit

14-Jun-2017 - Dr Reddy’s Laboratories says it has addressed the problems that earned its API plant in Miryalaguda, Talangana a US FDA Form 483 earlier this year.

News in brief

Johnson Matthey teams with Intrexon to make peptide API production more efficient

13-Jun-2017 - Johnson Matthey and Intrexon Corporation have teamed up to develop peptide active pharmaceutical ingredient (API) production methods.

Ingredients: Featured news

Key Industry Events


Access all events listing

Our events, Shows & Conferences...